Net unrealized gains (losses) on securities still held
Revolution Medicines, Inc. Net unrealized gains (losses) on securities still held decreased by 3282.6% to -$3.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1097.7%, from $386.00K to -$3.85M. Over 3 years (FY 2021 to FY 2025), Net unrealized gains (losses) on securities still held shows an upward trend with a 57.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase reflects positive market performance of the company's investment portfolio, potentially signaling latent liquidity.
Detailed definition
The change in the fair value of investment securities held by the company that are classified as available-for-sale or s...
Peer comparison
Standard for companies with significant cash reserves invested in marketable securities.
other_other_comprehensive_income_unrealized_holding_gain_503fecHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$123.00K | -$123.00K | -$123.00K | $581.00K | $581.00K | $581.00K | $581.00K | $1.22M | -$695.00K | $380.00K | $1.42M | -$1.74M | -$665.00K | $5.68M | $386.00K | -$405.00K | $1.81M | $121.00K | -$3.85M |
| QoQ Change | — | +0.0% | +0.0% | +572.4% | +0.0% | +0.0% | +0.0% | +110.7% | -156.8% | +154.7% | +272.4% | -223.1% | +61.8% | +953.4% | -93.2% | -204.9% | +547.9% | -93.3% | <-999% |
| YoY Change | — | — | — | — | +572.4% | +572.4% | +572.4% | +110.7% | -219.6% | -34.6% | +143.5% | -242.3% | +4.3% | >999% | +122.2% | +39.1% | -68.0% | — | <-999% |
Net unrealized gains (losses) on securities still held at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s net unrealized gains (losses) on securities still held?
- Revolution Medicines, Inc. (RVMD) reported net unrealized gains (losses) on securities still held of -$3.85M in Q1 2026.
- How has Revolution Medicines, Inc.'s net unrealized gains (losses) on securities still held changed year-over-year?
- Revolution Medicines, Inc.'s net unrealized gains (losses) on securities still held decreased by 1097.7% year-over-year, from $386.00K to -$3.85M.
- What is the long-term trend for Revolution Medicines, Inc.'s net unrealized gains (losses) on securities still held?
- Over 3 years (2021 to 2025), Revolution Medicines, Inc.'s net unrealized gains (losses) on securities still held has grown at a 57.3% compound annual growth rate (CAGR), from -$492.00K to $1.92M.
- What does net unrealized gains (losses) on securities still held mean?
- The change in value of investment holdings that have not yet been sold.